ReviewTheranostics2026
Functionalized metallic nanomaterials, nanozymes and nanomotors for emerging tumor diagnosis and treatment: from design to theranostics strategies.
Review in Theranostics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cancer is one of the most significant health issues and is the second leading cause of death worldwide. Traditional cancer diagnosis and treatment has serious defects and often fails to provide satisfactory results. Metallic nanomaterials, particularly gold-based nanomaterials, have been rapidly developed in the biomedical field, especially in the tumor theranostics owing to their unique morphological structures, outstanding physical and chemical properties, great biocompatibility and stability. With the development of research, researchers have introduced a second metal on the basis of single metallic nanomaterials to obtain bimetallic nanomaterials with better optical, catalytic and stability properties than single metallic nanomaterials. Based on the advantages of the above-mentioned metallic nanomaterials, many emerging types of metal-based materials have been developed accordingly. A typical example is metal-based nanozyme, which has inherent enzyme-like capabilities and has advantages such as great stability, abundant sources, controllable activity and low-cost preparation process compared with natural enzymes. The limited penetration of nanomaterials into tumor tissues is a major challenge in current cancer diagnosis and treatment. Further, another typical example is the metal-based nanomotor, which features a unique Janus structure and superior mobility, and is expected to enhance the deep penetration of nanomaterials into tumor, thereby improving the therapeutic effect of diseases. This review highlights the synthesis and properties of gold-based nanomaterials and bimetallic nanomaterials, with a focus on recent advances and future expectation in tumor diagnosis and treatment applications. With further research, we believe that the transition from metallic nanoparticles to metal nanozymes and then to metal enzymes-driven nanomotors will become important nanoplatforms for personalized cancer theranostics.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.